These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1228 related articles for article (PubMed ID: 30024653)

  • 1. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):251-268. PubMed ID: 30024653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE
    J Clin Endocrinol Metab; 2023 Sep; 108(10):2447-2469. PubMed ID: 37580314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; M Redman L; A Boyle J; Norman RJ; Mousa A; Joham AE;
    Fertil Steril; 2023 Oct; 120(4):767-793. PubMed ID: 37589624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome†.
    Teede HJ; Tay CT; Laven J; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Hum Reprod; 2023 Sep; 38(9):1655-1679. PubMed ID: 37580037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Tay CT; Laven JJE; Dokras A; Moran LJ; Piltonen TT; Costello MF; Boivin J; Redman LM; Boyle JA; Norman RJ; Mousa A; Joham AE;
    Eur J Endocrinol; 2023 Aug; 189(2):G43-G64. PubMed ID: 37580861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility.
    Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ;
    Hum Reprod Open; 2019; 2019(1):hoy021. PubMed ID: 31486807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise Recommendations for Women with Polycystic Ovary Syndrome: Is the Evidence Enough?
    Stepto NK; Patten RK; Tassone EC; Misso ML; Brennan L; Boyle J; Boyle RA; Harrison CL; Hirschberg AL; Marsh K; Moreno-Asso A; Redman L; Thondan M; Wijeyaratne C; Teede HJ; Moran LJ
    Sports Med; 2019 Aug; 49(8):1143-1157. PubMed ID: 31166000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Summary of the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome: an Australian perspective.
    Teede HJ; Mousa A; Tay CT; Costello MF; Brennan L; Norman RJ; Pena AS; Boyle JA; Joham A; Berry L; Moran L
    Med J Aust; 2024 Oct; 221(7):389-395. PubMed ID: 39223729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A brief update on the evidence supporting the treatment of infertility in polycystic ovary syndrome.
    Costello MF; Misso ML; Balen A; Boyle J; Devoto L; Garad RM; Hart R; Johnson L; Jordan C; Legro RS; Norman RJ; Moran L; Mocanu E; Qiao J; Rodgers RJ; Rombauts L; Tassone EC; Thangaratinam S; Vanky E; Teede HJ
    Aust N Z J Obstet Gynaecol; 2019 Dec; 59(6):867-873. PubMed ID: 31514246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.
    Teede HJ; Misso ML; Boyle JA; Garad RM; McAllister V; Downes L; Gibson M; Hart RJ; Rombauts L; Moran L; Dokras A; Laven J; Piltonen T; Rodgers RJ; Thondan M; Costello MF; Norman RJ;
    Med J Aust; 2018 Oct; 209(S7):S3-S8. PubMed ID: 30453865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management.
    Moran LJ; Tassone EC; Boyle J; Brennan L; Harrison CL; Hirschberg AL; Lim S; Marsh K; Misso ML; Redman L; Thondan M; Wijeyaratne C; Garad R; Stepto NK; Teede HJ
    Obes Rev; 2020 Oct; 21(10):e13046. PubMed ID: 32452622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescent polycystic ovary syndrome according to the international evidence-based guideline.
    Peña AS; Witchel SF; Hoeger KM; Oberfield SE; Vogiatzi MG; Misso M; Garad R; Dabadghao P; Teede H
    BMC Med; 2020 Mar; 18(1):72. PubMed ID: 32204714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-Scale Evidence-Based Guideline Development Engaging the International PCOS Community.
    Misso ML; Tassone EC; Costello MF; Dokras A; Laven J; Moran LJ; Teede HJ;
    Semin Reprod Med; 2018 Jan; 36(1):28-34. PubMed ID: 30189448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study.
    Copp T; Muscat DM; Hersch J; McCaffery KJ; Doust J; Mol BW; Dokras A; Jansen J
    Hum Reprod; 2020 Mar; 35(3):660-668. PubMed ID: 32101283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis delayed: health profile differences between women with undiagnosed polycystic ovary syndrome and those with a clinical diagnosis by age 35 years.
    Fernandez RC; Moore VM; Rumbold AR; Whitrow MJ; Avery JC; Davies MJ
    Hum Reprod; 2021 Jul; 36(8):2275-2284. PubMed ID: 33963388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International evidence-based guideline on assessment and management of PCOS-A Nordic perspective.
    Forslund M; Melin J; Stener-Victorin E; Hirschberg AL; Teede H; Vanky E; Piltonen T
    Acta Obstet Gynecol Scand; 2024 Jan; 103(1):7-12. PubMed ID: 37983875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.